(Q43609570)

25 November 2017

Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B. (English)

1 reference

25 November 2017

cutaneous leishmaniasis

1 reference

Vardy D

1

1 reference

25 November 2017

Barenholz Y

2

1 reference

25 November 2017

Naftoliev N

3

1 reference

25 November 2017

Klaus S

4

1 reference

25 November 2017

Gilead L

5

1 reference

25 November 2017

Frankenburg S

6

1 reference

25 November 2017

1 March 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

25 November 2017

1 reference

25 November 2017

95

1 reference

25 November 2017

2

1 reference

25 November 2017

184-186

1 reference

A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990158-0

7 January 2021

Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990158-0

7 January 2021

Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990158-0

7 January 2021

Changing patterns of cutaneous leishmaniasis in Israel and neighbouring territories

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990158-0

7 January 2021

Topical amphotericin B for cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990158-0

7 January 2021

10.1016/S0035-9203(01)90158-0

Identifiers

DOI

1 reference

25 November 2017

1 reference